Food Allergy Epidemiology Forecast

DelveInsight’s ‘Food Allergy–Epidemiology Forecast—2032’ report delivers an in-depth understanding of the Food Allergy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Canada and China.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
  • Canada
  • China

Study Period: 2019–2032

Food Allergy Disease Understanding 

According to National Institute of Allergy and Infectious Diseases (NIAID), a food allergy is an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food. Food allergens are the parts of food or ingredients within food (usually proteins) that are recognized by immune cells. When an immune cell binds to a food allergen, a reaction occurs that causes the symptoms of food allergy. “Allergy” and “allergic disease” refer to conditions that involve changes to the immune system. These immune system changes fall into two categories: Immunoglobulin E (IgE) mediated and Non-IgE-mediated.

 

The symptoms of food allergies range from mild discomfort to severe, life-threatening reactions, which require immediate medical intervention. Symptoms may be triggered in the skin (itching, redness, swelling), gastrointestinal tract (pain, vomiting, diarrhea, itching and swelling of oral cavity), respiratory tract (itching and swelling of the nose and throat, asthma), eyes (itching and swelling), and/or cardiovascular system (e.g. chest pain, abnormal heart rhythm).

 

The cause of food allergy can be functional genetic variants in the IL-12 receptor b1, Toll-like receptor 9, and thymic stromal lymphopoietin genes and even IL-4 gene polymorphism have been associated with an increased risk of food sensitization.

 

Diagnosis of a food allergy relies on patient history and physical exam. The most common diagnosis method for food allergy according to World Allergy Organization (WAO) include Skin prick tests (SPT), which is the preferred testing method in those patients with a history compatible with food allergies; double blind placebo-controlled food challenge (DBPCFC), which is the preferred test to diagnose food allergy; the in vitro diagnostics can help to identify cross-reactive allergens between pollen and foods, or foods and latex, and the atopy patch test (APT) is an epicutaneous skin test in which allergens commonly associated with IgE reactions can be used.

 

The treatment of food allergy relies on avoidance of the foods to which an individual is allergic, as therapeutic intervention (tertiary prevention) in patients with food allergy. Unfortunately, severe reactions such as anaphylaxis may occur despite best efforts in avoidance. Epinephrine is the first-line medication for the treatment of anaphylaxis. Additional medications include H1 and H2 antihistamines, corticosteroids, and prostaglandin synthetase inhibitors these drugs are only symptomatic, do not modify the natural course of the disease.

 

Treatment of food allergy is a rapidly changing landscape, with arguably, the most significant advancement in recent years, the transition of oral immunotherapy (OIT) to clinical practice. As an innovation, OIT is a phase of rapidly increasing demand, particularly for some allergens such as peanut, egg, and milk, which have substantial evidence of efficacy.

 

The Food Allergy market dynamics are anticipated to change in the coming years owing to the expected launch of emerging therapies by major key players in the treatment regime. The launch of various multiple-stage pipeline products will significantly revolutionize the Food Allergy market dynamics shortly. 

 

Visit to learn about the key factors, trends, innovations, and developments driving the market growth, at: Food Allergy Market 
 

Food Allergy Epidemiology 

The Food Allergy epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight’s report also provides the diagnosed patient pool and their trends along with assumptions undertaken. 

 

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Food Allergy epidemiology segmented as the Prevalent Cases of Food Allergy, Prevalent Cases of Food Allergy based on Etiology-specific factors, Age-specific Prevalence of Food Allergy. The report includes the prevalent scenario of Food Allergy in 7MM, Canada and China covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), Japan, Canada and China from 2019 to 2032. 

Country Wise- Food Allergy Epidemiology 

The epidemiology segment also provides the Food Allergy epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, Canada, and China. 

  • The total prevalent population of Food Allergy associated in 7MM, Canada and China countries was estimated to be 284,023,865 cases in 2019 and expected to increase at a CAGR of 0.18% for the study period, i.e., 2019–2032.
  • As per the estimates, CN has the highest prevalent population of Food Allergy in 7MM, Canada and China.
  • Among the EU-5 countries, Spain had the highest prevalent population of Food Allergy. On the other hand, UK had the lowest number of case 2,007,094 cases in 2019.

Scope of the Report

  • Food Allergy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
  • Food Allergy Epidemiology Report and Model provide an overview of the risk factors and global trends of Food Allergy in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, Japan, Canada, and China).
  • The report provides insight into the historical and forecasted patient pool of Food Allergy in nine major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, Canada, and China.
  • The report helps recognize the growth opportunities in the 7MM, Canada and China concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Food Allergy.
  • The report provides the segmentation of the Food Allergy epidemiology by prevalent cases of Food Allergy in 7MM, Canada and China.
  • The report provides the segmentation of the Food Allergy epidemiology by Prevalent Cases of Food Allergy, Prevalent Cases of Food Allergy based on Etiology-specific factors, Age-specific Prevalence of Food Allergy in 7MM, Canada and China.

Report Highlights

  • 11-year Forecast of Food Allergy epidemiology
  • 7MM, Canada and China Coverage 
  • Prevalent Cases of Food Allergy
  • Prevalent Cases of Food Allergy based on Etiology-specific factors
  • Age-specific Prevalence of Food Allergy 

KOL Views 

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM, Canada and China concerning the patient population about Food Allergy?
  • What are the key Findings of Food Allergy epidemiology across 7MM, Canada and China, and which country will have the highest number of patients during the forecast period (2019–2032)?
  • What would be the total number of patients with Food Allergy across the 7MM, Canada and China during the forecast period (2019–2032)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019–2032)?
  • At what CAGR the patient population is expected to grow by 7MM, Canada and China during the forecast period (2019–2032)?
  • What are the disease risk, burden, and unmet needs of Food Allergy?
  • What are the currently available treatments for Food Allergy?

Reasons to buy

The Food Allergy Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Food Allergy  market
  • Quantify patient populations in the global Food Allergy market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for Food Allergy therapeutics in each of the markets covered
  • Understand the magnitude of Food Allergy population by its prevalent cases
  • Understand the magnitude of Food Allergy population by its clinical manifestation specific cases
  • The Food Allergy epidemiology report and model was written and developed by Masters and PhD level epidemiologists
  • The Food Allergy Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 13-years forecast period using reputable sources

Key Assessments

  • Patient Segmentation 
  • Disease Risk and Burden
  • Risk of disease by the segmentation 
  • Factors driving growth in a specific patient population

1. Key Insights

2. Report Introduction

3. Food allergy Market Overview at a Glance

3.1. Market Share (%) Distribution of Food allergy in 2019

3.2. Market Share (%) Distribution of Food allergy in 2032

4. Executive Summary of Food allergy

5. Disease Background and Overview

5.1. Introduction

5.2. Etiology

5.3. Clinical Manifestations

5.4. Subtypes of Food Allergy

5.5. Diagnosis

6. Management and Treatment

6.1. Guidelines

6.2. American Guidelines for the Diagnosis and Management of Food allergies

6.3. The European Academy of Allergy and Clinical Immunology (EAACI) Guidelines

6.4. Japanese Guidelines for Food allergies

6.4.1. Symptom Severity and Treatment

6.4.1.1. Grading symptom severity

6.4.1.2. Treatment based on symptom severity

6.4.1.3. Evaluation of organ-specific symptoms

6.4.2. Management of Anaphylaxis in a Health Care Setting

6.4.2.1. Confirmation of vital signs

6.4.2.2. Ensuring staff and treatment by a team

6.4.2.3. Intramuscular injection of adrenaline

6.4.2.4. Body position of the anaphylaxis patients

6.4.2.5. Administration of oxygen

6.4.2.6. Securing the intravenous infusion route and rapid rehydration

6.4.2.7. Cessation of respiration

6.4.2.8. Measurement of vital signs: Re-evaluation

6.4.3. Contraindication of adrenaline

7. Epidemiology and Patient Population

7.1. Key Findings

7.2. 7MM, Canada and China Total Prevalent Patient Population of Food allergy

7.3. Assumption and Rationale

7.4. The United States

7.4.1. Prevalent cases of Food allergy in the United States

7.4.2. Prevalent Cases of Food allergy based on Etiology-specific factors in the United States

7.4.3. Age-specific Prevalence of Food allergy in the United States

7.5. EU5

7.5.1. Prevalent cases of Food allergy in the EU5

7.5.2. Prevalent Cases of Food allergy based on Etiology-specific factors in the EU5

7.5.3. Age-specific Prevalence of Food allergy in the EU5

7.6. Japan

7.6.1. Prevalent cases of Food allergy in Japan

7.6.2. Prevalent Cases of Food allergy based on Etiology-specific factors in Japan

7.6.3. Age-specific Prevalence of Food allergy in Japan

7.7. Canada

7.7.1. Prevalent cases of Food allergy in Canada

7.7.2. Prevalent Cases of Food allergy based on Etiology-specific factors in Canada

7.7.3. Age-specific Prevalence of Food allergy in Canada

7.8. China

7.8.1. Prevalent cases of Food allergy in China

7.8.2. Prevalent Cases of Food allergy based on Etiology-specific factors in China

7.8.3. Age-specific Prevalence of Food allergy in China

8. Patient Journey 1

9. Patient Journey 2

10. Appendix

10.1. Bibliography

10.2. Report Methodology

11. DelveInsight Capabilities

12. Disclaimer

13. About DelveInsight

List of Table

Table 1: Summary of Food allergy, Market, Epidemiology, and Key Events (2019–2032)

Table 2: Classification of Food Allergies

Table 3: Total Prevalent Patient Population of Food allergy in the 7MM, Canada and China (2019 –2032)

Table 4: Prevalent cases of Food allergy in the United States (2019–2032)

Table 5: Prevalent Cases of Food allergy based on Etiology-specific factor in the United States (2019–2032)

Table 6: Age-specific Prevalence of Food allergy in the United States (2019–2032)

Table 7: Prevalent cases of Food allergy in the EU5 (2019–2032)

Table 8: Prevalent Cases of Food allergy based on Etiology-specific factor in the EU5 (2019–2032)

Table 9: Age-specific Prevalence of Food allergy in the EU5 (2019–2032)

Table 10: Prevalent cases of Food allergy in Japan (2019–2032)

Table 11: Prevalent Cases of Food allergy based on Etiology-specific factors in Japan (2019–2032)

Table 12: Age-specific Prevalence of Food allergy in Japan (2019–2032)

Table 13: Prevalent cases of Food allergy in Canada (2019–2032)

Table 14: Prevalent Cases of Food allergy based on Etiology-specific factors in Canada (2019–2032)

Table 15: Age-specific Prevalence of Food allergy in Canada (2019–2032)

Table 16: Prevalent cases of Food allergy in China (2019–2032)

Table 17: Prevalent Cases of Food allergy based on Etiology-specific factors in China (2019–2032)

Table 18: Age-specific Prevalence of Food allergy in China (2019–2032)

List of Figures

Figure 1: Immune Cell Function

Figure 2: Total Prevalent Population of Food allergy in the 7MM, Canada and China (2019–2032)

Figure 3: Prevalent cases of Food allergy in the United States (2019–2032)

Figure 4: Prevalent Cases of Food allergy based on Etiology-specific factor in the United States (2019–2032)

Figure 5: Age-specific Prevalence of Food allergy in the United States (2019–2032)

Figure 6: Prevalent cases of Food allergy in the EU5 (2019–2032)

Figure 7: Prevalent Cases of Food allergy based on Etiology-specific factor in the EU5 (2019–2032)

Figure 8: Age-specific Prevalence of Food allergy in the EU5 (2019–2032)

Figure 9: Prevalent cases of Food allergy in Japan (2019–2032)

Figure 10: Prevalent Cases of Food allergy based on Etiology-specific factors in Japan (2019–2032)

Figure 11: Age-specific Prevalence of Food allergy in Japan (2019–2032)

Figure 12: Prevalent cases of Food allergy in Canada (2019–2032)

Figure 13: Prevalent Cases of Food allergy based on Etiology-specific factors in Canada (2019–2032)

Figure 14: Age-specific Prevalence of Food allergy in Canada (2019–2032)

Figure 15: Prevalent cases of Food allergy in China (2019–2032)

Figure 16: Prevalent Cases of Food allergy based on Etiology-specific factors in China (2019–2032)

Figure 17: Age-specific Prevalence of Food allergy in China (2019–2032)

Forward to Friend

Need A Quote